Search

Your search keyword '"Werdan, Karl"' showing total 1,563 results
Start Over Author "Werdan, Karl"
1,563 results on '"Werdan, Karl"'

4. Curriculum Klinische Akut- und Notfallmedizin – Schwerpunkt Innere Medizin: Empfehlung zu Weiterbildungsinhalten der Inneren Medizin in der Notaufnahme

Author

Busch, Hans-Jörg, Wolfrum, Sebastian, Michels, Guido, Baumgärtel, Matthias, Bodmann, Klaus-Friedrich, Buerke, Michael, Burst, Volker, Enghard, Philipp, Ertl, Georg, Fach, Wolf Andreas, Hanses, Frank, Heppner, Hans Jürgen, Hermes, Carsten, Janssens, Uwe, John, Stefan, Jung, Christian, Karagiannidis, Christian, Kiehl, Michael, Kluge, Stefan, Koch, Alexander, Kochanek, Matthias, Korsten, Peter, Lepper, Philipp M., Merkel, Martin, Müller-Werdan, Ursula, Neukirchen, Martin, Pfeil, Alexander, Riessen, Reimer, Rottbauer, Wolfgang, Schellong, Sebastian, Scherg, Alexandra, Sedding, Daniel, Singler, Katrin, Thieme, Marcus, Trautwein, Christian, Willam, Carsten, and Werdan, Karl

Published
2024
Full Text
View/download PDF

13. Cardiovascular risk factors, living and ageing in Halle: the CARLA study

Author

Hassan, Lamiaa, Efremov, Ljupcho, Großkopf, Anne, Kartschmit, Nadja, Medenwald, Daniel, Schott, Artjom, Schmidt-Pokrzywniak, Andrea, Lacruz, Maria E., Tiller, Daniel, Kraus, Frank Bernhard, Greiser, Karin H., Haerting, Johannes, Werdan, Karl, Sedding, Daniel, Simm, Andreas, Nuding, Sebastian, Kluttig, Alexander, and Mikolajczyk, Rafael

Published
2022
Full Text
View/download PDF

14. Einsatz der extrakorporalen Zirkulation (ECLS/ECMO) bei Herz- und Kreislaufversagen: Kurzversion der AWMF-S3-Leitlinie

Author

Boeken, Udo, Ensminger, Stephan, Assmann, Alexander, Schmid, Christof, Werdan, Karl, Michels, Guido, Miera, Oliver, Schmidt, Florian, Klotz, Stefan, Starck, Christoph, Pilarczyk, Kevin, Rastan, Ardawan, Burckhardt, Marion, Nothacker, Monika, Muellenbach, Ralf, Zausig, York, Haake, Nils, Groesdonk, Heinrich, Ferrari, Markus, Buerke, Michael, Hennersdorf, Marcus, Rosenberg, Mark, Schaible, Thomas, Köditz, Harald, Kluge, Stefan, Janssens, Uwe, Lubnow, Matthias, Flemmer, Andreas, Herber-Jonat, Susanne, Wessel, Lucas, Buchwald, Dirk, Maier, Sven, Krüger, Lars, Fründ, Andreas, Jaksties, Rolf, Fischer, Stefan, Wiebe, Karsten, Hartog, Christiane, Dzemali, Omer, Zimpfer, Daniel, Ruttmann-Ulmer, Elfriede, Schlensak, Christian, Kelm, Malte, and Beckmann, Andreas

Published
2021
Full Text
View/download PDF

15. Second Edition of the German–Austrian S3 Guideline “Infarction-Related Cardiogenic Shock: Diagnosis, Monitoring and Treatment”

Author

Pilarczyk, Kevin, primary, Boeken, Udo, additional, Russ, Martin, additional, Briegel, Josef, additional, Buerke, Michael, additional, Geppert, Alexander, additional, Janssens, Uwe, additional, Kelm, Malte, additional, Michels, Guido, additional, Schlitt, Axel, additional, Thiele, Holger, additional, Willems, Stephan, additional, Zeymer, Uwe, additional, Zwissler, Bernhard, additional, Delle-Karth, Georg, additional, Ferrari, Markus Wolfgang, additional, Figulla, Hans Reiner, additional, Heller, Axel, additional, Hindricks, Gerhard, additional, Pichler-Cetin, Emel, additional, Pieske, Burkert, additional, Prondzinsky, Roland, additional, Bauersachs, Johann, additional, Kopp, Ina, additional, Werdan, Karl, additional, and Thielmann, Matthias, additional

Published
2024
Full Text
View/download PDF

17. Impact of QRS misclassifications on heart-rate-variability parameters (results from the CARLA cohort study)

Author

Sauerbier, Frank, Haerting, Johannes, Sedding, Daniel, Mikolajczyk, Rafael, Werdan, Karl, Nuding, Sebastian, Greiser, Karin H., Swenne, Cees A., Kors, Jan A., Kluttig, Alexander, Sauerbier, Frank, Haerting, Johannes, Sedding, Daniel, Mikolajczyk, Rafael, Werdan, Karl, Nuding, Sebastian, Greiser, Karin H., Swenne, Cees A., Kors, Jan A., and Kluttig, Alexander

Abstract

Background Heart rate variability (HRV), an important marker of autonomic nervous system activity, is usually determined from electrocardiogram (ECG) recordings corrected for extrasystoles and artifacts. Especially in large population-based studies, computer-based algorithms are used to determine RR intervals. The Modular ECG Analysis System MEANS is a widely used tool, especially in large studies. The aim of this study was therefore to evaluate MEANS for its ability to detect non-sinus ECG beats and artifacts and to compare HRV parameters in relation to ECG processing. Additionally, we analyzed how ECG processing affects the statistical association of HRV with cardiovascular disease (CVD) risk factors. Methods 20-min ECGs from 1,674 subjects of the population-based CARLA study were available for HRV analysis. All ECGs were processed with the ECG computer program MEANS. A reference standard was established by experienced clinicians who visually inspected the MEANS-processed ECGs and reclassified beats if necessary. HRV parameters were calculated for 5-minute segments selected from the original 20-minute ECG. The effects of misclassified typified normal beats on i) HRV calculation and ii) the associations of CVD risk factors (sex, age, diabetes, myocardial infarction) with HRV were modeled using linear regression. Results Compared to the reference standard, MEANS correctly classified 99% of all beats. The averaged sensitivity of MEANS across all ECGs to detect non-sinus beats was 76% [95% CI: 74.1;78.5], but for supraventricular extrasystoles detection sensitivity dropped to 38% [95% CI: 36.8;38.5]. Time-domain parameters were less affected by false sinus beats than frequency parameters. Compared to the reference standard, MEANS resulted in a higher SDNN on average (mean absolute difference 1.4ms [95% CI: 1.0;1.7], relative 4.9%). Other HRV parameters were also overestimated as well (between 6.5 and 29%). The effect estimates for the association of CVD risk factor

Published
2024

18. Patient knowledge about risk factors, achievement of target values, and guideline-adherent secondary prevention therapies 12 months after acute myocardial infarction.

Author

Zeymer, Uwe, Goss, Franz, Kunadt, Marcel, Oldenburg, Susanne, Hochadel, Mathias, Thiele, Holger, Werdan, Karl, Wilke, Andreas, Schirmer, Stephan, Seiffert, Ulrich, Axthelm, Christoph, Kindler, Patrizia, Brinkhoff, Jens, Unger, Bariele, Taggeselle, Jens, Trautwein, Dorothea, Langel, Jörg, Häntze, Sandrina, Wolf, Uulrich, and Thelemann, Andreas

Published
2024
Full Text
View/download PDF

20. Blutdruckmessung in der NAKO – methodische Unterschiede, Blutdruckverteilung und Bekanntheit der Hypertonie im Vergleich zu anderen bevölkerungsbezogenen Studien in Deutschland

Author

Schikowski, Tamara, Wigmann, Claudia, Fuks, Kateryna B., Schipf, Sabine, Heier, Margit, Neuhauser, Hannelore, Sarganas, Giselle, Ahrens, Wolfgang, Becher, Heiko, Berger, Klaus, Brenner, Hermann, Castell, Stefanie, Damms-Machado, Antje, Dörr, Marcus, Ebert, Nina, Efremov, Ljupcho, Emmel, Carina, Felix, Stephan B., Fischer, Beate, Franzke, Claus-Werner, Gastell, Sylvia, Günther, Kathrin, Haerting, Johannes, Ittermann, Till, Jaeschke, Lina, Jagodzinski, Annika, Jöckel, Karl-Heinz, Kaaks, Rudolphe, Kalinowski, Sonja, Keil, Thomas, Kemmling, Yvonne, Kluttig, Alexander, Krist, Lilian, Kuss, Oliver, Legath, Nicole, Leitzmann, Michael, Lieb, Wolfgang, Löffler, Markus, Meinke-Franze, Claudia, Michels, Karin B., Mikolajczyk, Rafael, Moebus, Susanne, Nuding, Sebastian, Peters, Annette, Pischon, Tobias, Rückert-Eheberg, Ina-Maria, Schöttker, Ben, Schmidt, Börge, Schmidt, Carsten Oliver, Schulze, Matthias B., Stang, Andreas, Thiele, Inke, Thierry, Sigrid, Thorand, Barbara, Völzke, Henry, Waniek, Sabina, Werdan, Karl, Wirkner, Kerstin, and Greiser, Karin Halina

Published
2020
Full Text
View/download PDF

22. In der Notaufnahme

Author

Wilhelm, Joachim, Ebelt, Henning, Werdan, Karl, Werdan, Karl, editor, Müller-Werdan, Ursula, editor, Schuster, Hans-Peter, editor, and Brunkhorst, Frank M., editor

Published
2016
Full Text
View/download PDF

26. The Prognostic Value of a Liver Function Test Using Indocyanine Green (ICG) Clearance in Patients with Multiple Organ Dysfunction Syndrome (MODS).

Author

Haertel, Franz, Nuding, Sebastian, Reisberg, Diana, Peters, Martin, Werdan, Karl, Schulze, P. Christian, and Ebelt, Henning

Subjects
INDOCYANINE green, LIVER function tests, PROGNOSIS, INTENSIVE care units
Abstract

Background: Multiple organ dysfunction syndrome (MODS) is common in intensive care units (ICUs) and is associated with high mortality. Although there have been multiple investigations into a multitude of organ dysfunctions, little is known about the role of liver dysfunction. In addition, clinical and laboratory findings of liver dysfunction may occur with a significant delay. Therefore, the aim of this study was to investigate whether a liver function test, based on indocyanine green (ICG)-clearance, contains prognostic information for patients in the early phase of MODS. Methods: The data of this analysis were based on the MODIFY study, which included 70 critically ill patients of a tertiary medical ICU in the early phase of MODS (≤24 h after diagnosis by an APACHE II score ≥ 20 and a sinus rhythm ≥ 90 beats per minute, with the following subgroups: cardiogenic (cMODS) and septic MODS (sMODS)) over a period of 18 months. ICG clearance was characterized by plasma disappearance rate = PDR (%/min); it was measured non-invasively by using the LiMON system (PULSION Medical Systems, Feldkirchen, Germany). The PDR was determined on the day of study inclusion (baseline) and after 96 h. The primary endpoint of this analysis was 28-day mortality. Results: ICG clearance was measured in 44 patients of the MODIFY trial cohort, of which 9 patients had cMODS (20%) and 35 patients had sMODS (80%). Mean age: 59.7 ± 16.5 years; 31 patients were men; mean APACHE II score: 33.6 ± 6.3; 28-day mortality was 47.7%. Liver function was reduced in the total cohort as measured by a PDR of 13.4 ± 6.3%/min At baseline, there were no relevant differences between survivors and non-survivors regarding ICG clearance (PDR: 14.6 ± 6.1%/min vs. 12.1 ± 6.5%/min; p = 0.21). However, survivors showed better liver function than non-survivors after 96 h (PDR: 21.9 ± 6.3%/min vs. 9.2 ± 6.3%/min, p < 0.05). Consistent with these findings, survivors but not non-survivors show a significant improvement in the PDR (7.3 ± 6.3%/min vs. −2.9 ± 2.6%/min; p < 0.01) within 96 h. In accordance, receiver-operating characteristic curves (ROCs) at 96 h but not at baseline show a link between the PDR and 28-day mortality (PDR at 96 h: AUC: 0.87, 95% CI: 0.76–0.98; p < 0.01. Conclusions: In our study, we found that ICG clearance at baseline did not provide prognostic information in patients in the early stages of MODS despite being reduced in the total cohort. However, improvement of ICG clearance 96 h after ICU admission is associated with reduced 28-day mortality. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

28. Treatment of patients with multiple organ dysfunction syndrome (MODS) with an electromagnetic field coupled to biorhythmically defined impulse configuration: the MicrocircMODS study.

Author

Werdan, Karl, Nuding, Sebastian, Kühnert, Diethelm, Kolthoum, Ramzi, Schott, Artjom, Quitter, Felix, Wienke, Andreas, and Sedding, Daniel

Abstract

Background: To potentially improve impaired vasomotion of patients with multiple organ dysfunction syndrome (MODS), we tested whether an electromagnetic field of low flux density coupled with a biorhythmically defined impulse configuration (Physical Vascular Therapy BEMER®, PVT), in addition to standard care, is safe and feasible and might improve disturbed microcirculatory blood flow and thereby improve global haemodynamics. Methods: In a prospective, monocentric, one-arm pilot study, 10 MODS patients (APACHE II score 20–35) were included. Patients were treated, in addition to standard care, for 4 days with PVT (3 treatment periods of 8 min each day; day 1: field intensity 10.5 μT; day 2:14 μT, day 3:17.5 μT; day 4:21.0 μT). Primary endpoint was the effect of PVT on sublingual microcirculatory perfusion, documented by microvascular flow index (MFI). Patient safety, adverse events, and outcomes were documented. Results: An increase in MFI by approximately 25% paralleled 4-day PVT, with the increase starting immediately after the first PVT and lasting over the total 4-day treatment period. Concerning global haemodynamics (secondary endpoints), halving vasopressor use within 24 h, and haemodynamic stabilisation paralleled 4-day PVT with an increase in cardiac index, stroke volume index, and cardiac power index by 30%–50%. No adverse events (AEs) or serious adverse events (SAEs) were classified as causally related to the medical product (PVT) or study. Three patients died within 28 days and one patient between 28 and 180 days. Conclusion: PVT treatment was feasible and safe and could be performed without obstruction of standard patient care. An increase in microcirculatory blood flow, a rapid reduction in vasopressor use, and an improvement in global haemodynamics paralleled PVT treatment. Findings of this pilot study allowed forming a concept for a randomized trial for further proof. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

31. Anaphylaktischer Schock

Author

Müller-Werdan, Ursula, Werdan, Karl, Marx, Gernot, editor, Muhl, Elke, editor, Zacharowski, Kai, editor, and Zeuzem, Stefan, editor

Published
2015
Full Text
View/download PDF

32. Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)

Author

Welte, Tobias, Dellinger, R. Phillip, Ebelt, Henning, Ferrer, Miguel, Opal, Steven M., Singer, Mervyn, Vincent, Jean-Louis, Werdan, Karl, Martin-Loeches, Ignacio, Almirall, Jordi, Artigas, Antonio, Ignacio Ayestarán, Jose, Nuding, Sebastian, Ferrer, Ricard, Sirgo Rodríguez, Gonzalo, Shankar-Hari, Manu, Álvarez-Lerma, Francisco, Riessen, Reimer, Sirvent, Josep-Maria, Kluge, Stefan, Zacharowski, Kai, Bonastre Mora, Juan, Lapp, Harald, Wöbker, Gabriele, Achtzehn, Ute, Brealey, David, Kempa, Axel, Sánchez García, Miguel, Brederlau, Jörg, Kochanek, Matthias, Reschreiter, Henrik Peer, Wise, Matthew P., Belohradsky, Bernd H., Bobenhausen, Iris, Dälken, Benjamin, Dubovy, Patrick, Langohr, Patrick, Mayer, Monika, Schüttrumpf, Jörg, Wartenberg-Demand, Andrea, Wippermann, Ulrike, Wolf, Daniele, and Torres, Antoni

Published
2018
Full Text
View/download PDF

38. Intraaortic Balloon Pump in Cardiogenic Shock Complicating Acute Myocardial Infarction: Long-Term 6-Year Outcome of the Randomized IABP-SHOCK II Trial

Author

Thiele, Holger, Zeymer, Uwe, Thelemann, Nathalie, Neumann, Franz-Josef, Hausleiter, Jörg, Abdel-Wahab, Mohamed, Meyer-Saraei, Roza, Fuernau, Georg, Eitel, Ingo, Hambrecht, Rainer, Böhm, Michael, Werdan, Karl, Felix, Stephan B., Hennersdorf, Marcus, Schneider, Steffen, Ouarrak, Taoufik, Desch, Steffen, and de Waha-Thiele, Suzanne

Published
2019
Full Text
View/download PDF

40. The differential statin effect on cytokine production of monocytes or macrophages is mediated by differential geranylgeranylation-dependent Rac1 activation

Author

Fu, Hang, Alabdullah, Mohamad, Großmann, Julia, Spieler, Florian, Abdosh, Reem, Lutz, Veronika, Kalies, Katrin, Knöpp, Kai, Rieckmann, Max, Koch, Susanne, Noutsias, Michel, Pilowski, Claudia, Dutzmann, Jochen, Sedding, Daniel, Hüttelmaier, Stefan, Umezawa, Kazuo, Werdan, Karl, and Loppnow, Harald

Published
2019
Full Text
View/download PDF

44. Use of extracorporeal circulation (ECLS/ECMO) for cardiac and circulatory failure –A clinical practice Guideline Level 3

Author

Assmann, Alexander, Beckmann, Andreas, Schmid, Christof, Werdan, Karl, Michels, Guido, Miera, Oliver, Schmidt, Florian, Klotz, Stefan, Starck, Christoph, Pilarczyk, Kevin, Rastan, Ardawan, Burckhardt, Marion, Nothacker, Monika, Muellenbach, Ralf, Zausig, York, Haake, Nils, Groesdonk, Heinrich, Ferrari, Markus, Buerke, Michael, Hennersdorf, Marcus, Rosenberg, Mark, Schaible, Thomas, Köditz, Harald, Kluge, Stefan, Janssens, Uwe, Lubnow, Matthias, Flemmer, Andreas, Herber‐Jonat, Susanne, Wessel, Lucas, Buchwald, Dirk, Maier, Sven, Krüger, Lars, Fründ, Andreas, Jaksties, Rolf, Fischer, Stefan, Wiebe, Karsten, Hartog, Christiane S., Dzemali, Omer, Zimpfer, Daniel, Ruttmann‐Ulmer, Elfriede, Schlensak, Christian, Kelm, Malte, Ensminger, Stephan, and Boeken, Udo

Subjects
Extracorporeal Circulation, Shock, Original Articles, Extracorporeal life support (ECLS), Guideline, Recommendation, Extracorporeal membrane oxygenation (ECMO), Extracorporeal Membrane Oxygenation, Germany, RC666-701, Practice Guidelines as Topic, Humans, Diseases of the circulatory (Cardiovascular) system, Original Article, Cardiac and circulatory failure
Abstract

Aims Worldwide applications of extracorporeal circulation for mechanical support in cardiac and circulatory failure, which are referred to as extracorporeal life support (ECLS) or veno‐arterial extracorporeal membrane oxygenation (va‐ECMO), have dramatically increased over the past decade. In spite of the expanding use and the immense medical as well as socio‐economic impact of this therapeutic approach, there has been a lack of interdisciplinary recommendations considering the best available evidence for ECLS treatment. Methods and Results In a multiprofessional, interdisciplinary scientific effort of all scientific societies involved in the treatment of patients with acute cardiac and circulatory failure, the first evidence‐ and expert consensus‐based guideline (level S3) on ECLS/ECMO therapy was developed in a structured approach under regulations of the AWMF (Association of the Scientific Medical Societies in Germany) and under use of GRADE (Grading of Recommendations Assessment, Development and Evaluation) criteria. This article presents all recommendations created by the expert panel, addressing a multitude of aspects for ECLS initiation, continuation, weaning and aftercare as well as structural and personnel requirements. Conclusions This first evidence‐ and expert consensus‐based guideline (level S3) on ECLS/ECMO therapy should be used to apply the best available care nationwide. Beyond clinical practice advice, remaining important research aspects for future scientific efforts are formulated.

Published
2022

45. The ICM research agenda on extracorporeal life support

Author

Combes, Alain, Brodie, Dan, Chen, Yih-Sharng, Fan, Eddy, Henriques, José P. S., Hodgson, Carol, Lepper, Philipp M., Leprince, Pascal, Maekawa, Kunihiko, Muller, Thomas, Nuding, Sebastian, Ouweneel, Dagmar M., Roch, Antoine, Schmidt, Matthieu, Takayama, Hiroo, Vuylsteke, Alain, Werdan, Karl, and Papazian, Laurent

Published
2017
Full Text
View/download PDF

46. Culprit lesion location and outcome in patients with cardiogenic shock complicating myocardial infarction: a substudy of the IABP-SHOCK II-trial

Author

Fuernau, Georg, Fengler, Karl, Desch, Steffen, Eitel, Ingo, Neumann, Franz-Josef, Olbrich, Hans-Georg, de Waha, Antoinette, de Waha, Suzanne, Richardt, Gert, Hennersdorf, Marcus, Empen, Klaus, Hambrecht, Rainer, Jung, Christian, Böhm, Michael, Pöss, Janine, Strasser, Ruth H., Schneider, Steffen, Ouarrak, Taoufik, Schuler, Gerhard, Werdan, Karl, Zeymer, Uwe, and Thiele, Holger

Published
2016
Full Text
View/download PDF

47. Anaphylaktischer Schock

Author

Müller-Werdan, Ursula, Werdan, Karl, Burchardi, H., editor, Larsen, R., editor, Marx, G., editor, Muhl, E., editor, and Schölmerich, J., editor

Published
2011
Full Text
View/download PDF

48. Extracorporeal Life Support Use in Cardiac and Circulatory Failure: A Summary of Recently Published S3 Guidelines

Author

Dzemali, Omer, primary, Starck, Christoph, additional, Wessel, Lukas, additional, Miera, Oliver, additional, Werdan, Karl, additional, Burckhardt, Marion, additional, Muellenbach, Ralf, additional, Jaksties, Rolf, additional, Schmidt, Florian, additional, Wiebe, Karsten, additional, Schmid, Christof, additional, Kluge, Stefan, additional, Pilarczyk, Kevin, additional, Haake, Nils, additional, Schaible, Thomas, additional, Flemmer, Andreas, additional, Klotz, Stefan, additional, Assmann, Alexander, additional, Janssens, Uwe, additional, Lubnow, Matthias, additional, Herber-Jonat, Susanne, additional, Ferrari, Markus, additional, Buchwald, Dirk, additional, Ensminger, Stephan, additional, Zausig, York, additional, Beckmann, Andreas, additional, Rosenberg, Mark, additional, Kelm, Malte, additional, Hennersdorf, Marcus, additional, Hartog, Christiane, additional, Fischer, Stefan, additional, Rastan, Ardawan, additional, Zimpfer, Daniel, additional, Frnd, Andreas, additional, Maier, Sven, additional, Ruttmann-Ulmer, Elfriede, additional, Groesdonk, Heinrich, additional, Schlensak, Christian, additional, Nothacker, Monika, additional, Buerke, Michael, additional, Kditz, Harald, additional, Michels, Guido, additional, Krger, Lars, additional, and Boeken, Udo, additional

Published
2022
Full Text
View/download PDF

49. Neutrophil-to-Lymphocyte Ratio and Outcomes in Patients Admitted for Acute Heart Failure (As Seen in the BLAST-AHF, Pre-RELAX-AHF, and RELAX-AHF Studies)

Author

Davison, Beth A., primary, Takagi, Koji, additional, Edwards, Christopher, additional, Adams, Kirkwood F., additional, Butler, Javed, additional, Collins, Sean P., additional, Dorobantu, Maria I., additional, Ezekowitz, Justin A., additional, Filippatos, Gerasimos, additional, Greenberg, Barry H., additional, Levy, Phillip D., additional, Masip, Josep, additional, Metra, Marco, additional, Pang, Peter S., additional, Ponikowski, Piotr, additional, Severin, Thomas M., additional, Teerlink, John R., additional, Teichman, Sam L., additional, Voors, Adriaan A., additional, Werdan, Karl, additional, and Cotter, Gad, additional

Published
2022
Full Text
View/download PDF

50. Empfehlungen der S3-Leitlinie (AWMF) „Einsatz der extrakorporalen Zirkulation (ECLS/ECMO) bei Herz- und Kreislaufversagen“

Author

Fischer, Stefan, additional, Assmann, Alexander, additional, Beckmann, Andreas, additional, Schmid, Christof, additional, Werdan, Karl, additional, Michels, Guido, additional, Miera, Oliver, additional, Schmidt, Florian, additional, Klotz, Stefan, additional, Starck, Christoph, additional, Pilarczyk, Kevin, additional, Rastan, Ardawan J., additional, Burckhardt, Marion, additional, Nothacker, Monika, additional, Muellenbach, Ralf, additional, Zausig, York, additional, Haake, Nils, additional, Goesdonk, Heinrich, additional, Ferrari, Markus Wolfgang, additional, Buerke, Michael, additional, Hennersdorf, Marcus, additional, Rosenberg, Mark, additional, Schaible, Thomas, additional, Köditz, Harald, additional, Kluge, Stefan, additional, Janssens, Uwe, additional, Lubnow, Matthias, additional, Flemmer, Andreas, additional, Herber-Jonat, Susanne, additional, Wessel, Lucas M, additional, Buchwald, Dirk, additional, Maier, Sven, additional, Krüger, Lars, additional, Fründ, Andreas, additional, Jaksties, Rolf, additional, Wiebe, Karsten, additional, Hartog, Christiane, additional, Dzemali, Omer, additional, Zimpfer, Daniel, additional, Ruttmann-Ulmer, Elfriede, additional, Schlensak, Christian, additional, Ensminger, Stephan, additional, Kelm, Malte, additional, and Boeken, Udo, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results